miRNA-148b and its role in various cancers-Reference-Cited by-同舟云学术

miRNA-148b and its role in various cancers

Published:2021-12 Issue:24 Volume:13 Page:1939-1960
ISSN:1750-1911
Container-title:Epigenomics
language:en
Short-container-title:Epigenomics

Author:

Dorraki Najmeh¹,Ghale-Noie Zari Naderi¹,Ahmadi Nooshin Sadegh²,Keyvani Vahideh³^ORCID,Bahadori Rosita Azar⁴,Nejad Arash Salmani¹,Aschner Michael⁵^ORCID,Pourghadamyari Hossein⁶⁷,Mollazadeh Samaneh⁸^ORCID,Mirzaei Hamed⁹¹⁰^ORCID

Affiliation:

1. Department of Medical Genetics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

2. Department of Genetics, Faculty of Medicine, Tehran Medical Sciences Islamic Azad University, Tehran, Iran

3. Department of Biology, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran

4. Department of Biology, Parand Branch, Islamic Azad University, Tehran, Iran

5. Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY, USA

6. Department of Clinical Biochemistry, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

7. Student Research Committee, Kerman University of Medical Sciences, Kerman, Iran

8. Natural Products & Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran

9. Research Center for Biochemistry & Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran

10. Student Research Committee, Kashan University of Medical Sciences, Kashan, Iran

Abstract

miRNA-148b belongs to the family miR-148/-152, with significant differences in nonseed sequences, which can target diverse mRNA molecules. Reportedly, it may undergo deregulation in lung and ovarian cancers and downregulation in gastric, pancreatic and colon cancers. However, there is a need for further studies to better characterize its mechanism of action and in different types of cancer. In this review, we focus on the aberrant expression of miR-148b in different cancer types and highlight its main target genes and signaling pathways, as well as its pathophysiologic role and relevance to tumorigenesis in several types of cancer.

Publisher

Future Medicine Ltd

Subject

Cancer Research,Genetics

Link

https://www.futuremedicine.com/doi/pdf/10.2217/epi-2021-0155

Reference176 articles.

1. MicroRNA-195: a review of its role in cancers

2. Microarray analysis of long non-coding RNAs related to microRNA-148b in gastric cancer

3. Exosomal microRNAs and exosomal long non-coding RNAs in gynecologic cancers

4. Colorimetric detection of miRNA-21 by DNAzyme-coupled branched DNA constructs

5. MicroRNA in leukemia: Tumor suppressors and oncogenes with prognostic potential

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in RNA therapeutics for modulation of ‘undruggable’ targets;Progress in Molecular Biology and Translational Science;2024

2. The crosstalk between non-coding RNA polymorphisms and resistance to lung cancer therapies;Heliyon;2023-10

3. MicroRNA-155 and cancer metastasis: Regulation of invasion, migration, and epithelial-to-mesenchymal transition;Pathology - Research and Practice;2023-10

4. Análisis de marcadores tumorales en pacientes con tumores estromales gastrointestinales GIST;Salud, Ciencia y Tecnología;2023-08-27

5. Transitional Insight into the RNA-Based Oligonucleotides in Cancer Treatment;Applied Biochemistry and Biotechnology;2023-07-04